FdaApplication

NDA 208147

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTRIS PHARMA INC
application_typeNDA
approval_date2015-10-19

Products (1)

ProductActive ingredientStrengthDosage form
DYANAVEL XRAMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE2MG/ML;EQ 0.5MG BASE/MLSUSPENSION, EXTENDED RELEASE;ORAL

1 product